Live Breaking News & Updates on Exact Sciences Precision Oncology Portfolio

Stay updated with breaking news from Exact sciences precision oncology portfolio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

/PRNewswire/ Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations. ....

San Antonio , United States , United Kingdom , Josepha Sparano , Gisela Pedroza , Rick Baehner , Federico Maiardi , Megan Jones , Sciences Corp , Sciences On Facebook , National Cancer Institute , Sciences On Twitter Exactsciences , Cancer Research Group , Exchange Commission , Genomic Health Inc , Sciences Precision Oncology Portfolio , Cancer Research Network , Sciences Corporation , Exact Science , Exact Sciences , Precision Oncology , Antonio Breast Cancer , Recurrence Score , Research Group , Trial Assigning Individualized Options , Tisch Cancer Center ,

EXACT SCIENCES CORP: Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS 2022

New independent clinical evidence from the pivotal TAILORx and RxPONDER trials support the role of the Oncotype DX Breast Recurrence Score test, the only genomic test to predict chemotherapy ....

San Antonio , United States , United Kingdom , Josepha Sparano , Gisela Pedroza , Rick Baehner , Federico Maiardi , Megan Jones , Sciences Corp , Sciences On Facebook , National Cancer Institute , Sciences On Twitter Exactsciences , Cancer Research Group , Exchange Commission , Prnewswire Exact Sciences Corp , Genomic Health Inc , Sciences Precision Oncology Portfolio , Cancer Research Network , Sciences Corporation , Exact Science , Precision Oncology , Antonio Breast Cancer , Recurrence Score , Research Group , Trial Assigning Individualized Options , Tisch Cancer Center ,

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

/PRNewswire/ Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations. ....

San Antonio , United States , United Kingdom , Josepha Sparano , Gisela Pedroza , Rick Baehner , Federico Maiardi , Megan Jones , Sciences Corp , Sciences On Facebook , National Cancer Institute , Sciences On Twitter Exactsciences , Cancer Research Group , Exchange Commission , Genomic Health Inc , Sciences Precision Oncology Portfolio , Cancer Research Network , Sciences Corporation , Exact Science , Exact Sciences , Precision Oncology , Antonio Breast Cancer , Recurrence Score , Research Group , Trial Assigning Individualized Options , Tisch Cancer Center ,